Healthcare research multiple myeloma (MM) - parameters to be assessed within the evaluation of the MM-Tumorboard (TB).

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00008587

Enrollment

299

Registered

2015-05-29

Start date

2014-03-03

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C90.0

Interventions

Group 1: The tunorboard (TB) for patients with multiple myeloma (MM) was initiated in 06/2012. t's an interdisciplinary conference with hematology/oncology, orthopedics, pathology, radiation therapy,

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with multiple myeloma presented and discussed at the tumorboard.

Exclusion criteria

Exclusion criteria: none.

Design outcomes

Primary

Measure	Time frame
a. discussed tumorboard-questions b. given recommendations c. parameters to be assessed within the evaluation of the tumorboard for patients with multiple myeloma (patient characteristics)	—

Countries

Germany

Contacts

Public ContactMonika Engelhardt Engelhardt

Uniklinik Freiburg

monika.engelhardt@uniklinik-freiburg.de+49 761 270 32460

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026